Nikko Asset Management Americas, Inc. - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 299 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.39 and the average weighting 0.2%.

Quarter-by-quarter ownership
Nikko Asset Management Americas, Inc. ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$111,170,916
-19.6%
3,520,295
+3.7%
1.33%
-8.7%
Q2 2023$138,298,285
+24.1%
3,394,656
+9.0%
1.46%
+13.4%
Q1 2023$111,444,111
+7.4%
3,112,964
+4.6%
1.28%
-14.1%
Q4 2022$103,743,430
-36.9%
2,976,002
+0.4%
1.49%
-28.9%
Q3 2022$164,498,000
+16.5%
2,963,928
+6.6%
2.10%
+20.5%
Q2 2022$141,143,000
-26.7%
2,781,136
-3.2%
1.74%
+23.4%
Q1 2022$192,442,000
-41.3%
2,872,269
+4.3%
1.41%
-18.0%
Q4 2021$327,714,000
+1.7%
2,753,903
+14.7%
1.72%
+24.6%
Q3 2021$322,191,000
-36.5%
2,399,933
-21.7%
1.38%
-30.4%
Q2 2021$507,307,000
+30.5%
3,063,449
-36.7%
1.99%
+4.3%
Q1 2021$388,697,000
+40.0%
4,843,270
-5.1%
1.90%
+20.7%
Q4 2020$277,677,000
+127.9%
5,104,362
-15.8%
1.58%
+46.0%
Q3 2020$121,857,000
-1.5%
6,062,516
-2.0%
1.08%
-33.3%
Q2 2020$123,671,000
-28.7%
6,183,547
-56.4%
1.62%
-0.4%
Q1 2020$173,452,000
+64.7%
14,182,526
+97.6%
1.63%
-1.9%
Q4 2019$105,309,000
+9.0%
7,178,520
-0.8%
1.66%
-3.4%
Q3 2019$96,650,000
+14.4%
7,239,737
+40.3%
1.72%
+3.6%
Q2 2019$84,487,000
+361.7%
5,161,098
+381.7%
1.66%
+243.1%
Q1 2019$18,299,000
+22215.9%
1,071,354
+17815.6%
0.48%
+16000.0%
Q4 2018$82,000
-41.8%
5,980
+20.0%
0.00%
-25.0%
Q3 2018$141,0004,9850.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,216,340$62,958,0007.04%
Discovery Value Fund 584,483$30,253,0006.33%
MPM BioImpact LLC 299,409$15,497,0004.30%
ARK Investment Management 9,514,580$439,003,0002.60%
Elmwood Wealth Management, Inc. 67,899$3,514,0002.00%
Nikko Asset Management Americas, Inc. 2,781,136$141,143,0001.74%
Avidity Partners Management LP 1,125,194$58,240,0001.34%
Merlin Capital, Inc 12,174$630,0001.26%
Atlas Venture Associates IX, LLC 10,000$518,0001.18%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$5,768,0001.16%
View complete list of INTELLIA THERAPEUTICS INC shareholders